Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
HILS Hillstream BioPharma
1.370+0.130+10.48%
Close
02/08 16:00 ET
1.330-0.040-2.92%
Pre Mkt Price 02/09 08:04 ET
High
1.490
Open
1.400
Turnover
2.37M
Low
1.284
Pre Close
1.240
Volume
1.71M
Pre-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2023 Annual Meeting Highlighting HSB-510 as Novel Bi-functional Inhibitor for Solid Tumors & Leukemias
An abstract highlighting the progress of the Quatramer-based dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, and navitoclax (BCL-XL/BCL-2 inhibitor) has been scheduled for presentation in a Poster Sess
Weekly FDA Drug Pipeline Calendar (Feb 6 - Feb 10)
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week.
Canada Goose Holdings, Hanesbrands Among Premarket Losers' Pack
Quoin, F-star Top Healthcare Gainers; Evelo, Taysha Lead Losers' Pack
Electronic Arts, Snap, Synchrony Financial Among Premarket Losers' Pack
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersQuoin Pharmaceuticals (NASDAQ:QNRX) stock rose 76.6% to $2.95 during Wednesday's pre-market session. The company's market cap stands at $14.2 million. TransCode Therapeutics (NASDAQ:RNAZ) stock
Sector Update: Health Care Stocks Advancing Tuesday Afternoon
01:38 PM EST, 01/31/2023 (MT Newswires) -- Health care stocks were trending higher Tuesday afternoon, with the NYSE Health Care Index rising 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0
Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Motorsport Games Inc. (NASDAQ:MSGM) shares jumped 770% to $22.99. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,98
Sector Update: Health Care
01:05 PM EST, 01/31/2023 (MT Newswires) -- Health care stocks were trending higher this afternoon, with the NYSE Health Care Index rising 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%
Hillstream Adds Over 100% on Licensing Deal With Dana-Farber
Company Overview
More
Hillstream BioPharma, Inc. is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (IMCD) for drug resistant and devastating cancers. It also develops the Trident Artificial Intelligence (TAI) precision medicine platform which is used to identify biomarkers in its clinical programs to target a specific patient segment. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
CEO： Mr. Randy Milby
Market： NASDAQ
Listing Date： 01/12/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet